Kidney Organoids Reveal Inflammatory Drivers of Diabetic Kidney Disease
In kidney organoids, elevated glucose triggered tissue-intrinsic inflammation and epithelial cell detachment without overt cytotoxicity. Inhibiting MIF, TNF-alpha, or MAPK-related signaling helped protect the organoids, suggesting inflammatory pathways may be targetable in diabetic kidney disease. The post Kidney Organoids Reveal Inflammatory Drivers of Diabetic Kidney Disease appeared first on…
Diabetic kidney disease, a prevalent and severe complication of diabetes, remains poorly understood. A recent study reveals that elevated glucose levels can trigger tissue-intrinsic inflammation within kidney tissue, potentially damaging epithelial cells. Human kidney organoids, derived from pluripotent stem cells, were exposed to varying glucose concentrations to mimic diabetic conditions.
Organoids in higher glucose environments displayed progressive morphological changes, with detachment of podocytes and tubular epithelial cells, a phenomenon observed in kidney biopsies and urine samples from diabetic patients. Single-cell RNA sequencing identified upregulation of inflammatory genes such as MIF and TNF-alpha, as well as activation of the TNF-alpha/NF-kB signaling pathway in high-glucose organoids.
Inhibiting these inflammatory pathways, specifically MIF with ISO-1 and TNF-alpha with etanercept, protected organoids from podocyte injury under high-glucose conditions. While the study provides a controlled human platform for investigating how hyperglycemia affects kidney cells and evaluating potential anti-inflammatory strategies, further research is needed to translate these findings into patient therapies.
Written by urgent.news from GEN Biotechnology's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
